The reason behind Unnecessary Mastectomies


Woman sues over allegedly unnecessary hysterectomy, mastectomy

Video taken from the channel: CBS This Morning


Top Reasons for Undergoing a Double Mastectomy

Video taken from the channel: The Doctors


Double mastectomies unnecessary in most breast cancer patients

Video taken from the channel: insidermedicine


“Botched” Patient Got an Unnecessary Double Mastectomy?! | E!

Video taken from the channel: E! Entertainment


Unnecessary Mastectomies Called Uncommon

Video taken from the channel: MedPage Today


Why Double Mastectomy is Unnecessary.

Video taken from the channel: MedStar Washington Hospital Center


Do some breast cancer patients have unnecessary mastectomies?

Video taken from the channel: North Florida Regional Medical Center

WEDNESDAY, April 12, 2017 (HealthDay News)—Close to half of breast cancer patients who chose to have a double mastectomy after genetic testing didn’t actually have the gene mutations known to raise the risk of additional cancers, a new survey found. “That was a bit surprising, because we wouldn’t typically expect that surgery to be conducted for women if they don’t have a risk-causing gene. The procedure is often recommended for women with a genetic mutation that puts them at high risk of developing a second cancer. But for women at average risk, the surgery offers little benefit. A recent study, published online Dec. 21, 2016, by JAMA Surgery, helps to explain why so many women are opting for double mastectomy.

New breast cancer research shows the rate of preventative double mastectomies has more than tripled in the last decade. Mastectomy rates have skyrocketed for an unnecessary reason – SheKnows. Lumpectomy with radiation is often more expensive than mastectomy, so financial incentives may also contribute to unnecessary mastectomies. Studies of low-income women indirectly support concerns that breast cancer patients are making surgical decisions that may not be based on informed choice. The Psychology of ‘Unnecessary’ Mastectomies.

By Melissa Dahl. Photo: Hero Images/Corbis. It’s becoming a more common medical story: A woman is diagnosed with cancer in one breast, and she chooses to undergo a mastectomy — not just to remove the affected breast, but the other one, too. A key premise here, sadly — and maddeningly — is that insurance companies are driving the trend toward drive-by mastectomies.

The finger of blame has pointed that way for years. Indeed, some 10 years ago, patient advocates in 20 states successfully lobbied their local legislators to make it illegal for insurers to impose rates that force women out of the hospital less than 48 hours after breast. Unnecessary mastectomies: Patients more fearful than they need to be any risk of cancer developing in the other breast was cited an “extremely important” or “very important” reason by. Or are these procedures unnecessary? preventative double mastectomies made up 20 percent of total mastectomies in 2008 compared to saying prevention of recurrence was the leading reason. Breast cancer experts believe that many women undergoing mastectomies do not need them and are getting them out of fear, not because of the actual risks.

In recent years, we have seen an increase in women with early-stage breast cancer choosing to get a double mastectomy. Learn why preventive mastectomy is done and how it affects breast cancer risk. Includes contralateral prophylactic mastectomy.

List of related literature:

Although it carries an equivalent risk of deep venous thrombosis to oestrogen, it confers a reduction in the risk of breast cancer.

“Medicine at a Glance” by Patrick Davey
from Medicine at a Glance
by Patrick Davey
Wiley, 2014

When a woman with an intact uterus takes estrogen orally or transdermally, a progestin is added to counter abnormal endometrial growth.47 However, there exists a controversy about the need for a progestin when a woman uses a topical estrogen such as creams and rings for vaginal atrophy.

“Pharmacology for Women's Health” by King, Tekoa L. King, Mary C. Brucker
from Pharmacology for Women’s Health
by King, Tekoa L. King, Mary C. Brucker
Jones & Bartlett Learning, 2010

Estrogen preparations are used in the treatment of primary hypogonadism, including cases caused by surgical oophorectomy, menopause, and other causes.

“Pharmacology E-Book: with STUDENT CONSULT Online Access” by George M. Brenner, Craig W. Stevens
from Pharmacology E-Book: with STUDENT CONSULT Online Access
by George M. Brenner, Craig W. Stevens
Elsevier Health Sciences, 2012

Because 5β-androgens (which bind weakly to ARs) are more effective than 5α-androgens, this may constitute a novel mechanism explaining the direct effect of androgens on bone marrow cells.

“Brody's Human Pharmacology E-Book” by Lynn Wecker, Lynn Crespo, George Dunaway, Carl Faingold, Stephanie Watts
from Brody’s Human Pharmacology E-Book
by Lynn Wecker, Lynn Crespo, et. al.
Elsevier Health Sciences, 2009

In addition, prophylactic mastectomies are sometimes indicated in patients at high risk for the development of cancer due to a strong family history, genetic predisposition, or previously noted atypia.

“Surgery: Basic Science and Clinical Evidence” by Jeffrey Norton, R.Randall Bollinger, Alfred E. Chang, Stephen F. Lowry
from Surgery: Basic Science and Clinical Evidence
by Jeffrey Norton, R.Randall Bollinger, et. al.
Springer Berlin Heidelberg, 2012

Continued use of oestrogens can increase the risk of endometrial carcinoma, gallbladder disease and thromboembolic disorders; because of the danger of damage to the fetus all female sex hormones are contraindicated during pregnancy.

“Mosby's Dictionary of Medicine, Nursing and Health Professions Australian & New Zealand Edition eBook” by Peter Harris, Sue Nagy, Nicholas Vardaxis
from Mosby’s Dictionary of Medicine, Nursing and Health Professions Australian & New Zealand Edition eBook
by Peter Harris, Sue Nagy, Nicholas Vardaxis
Elsevier Health Sciences, 2014

Raloxifene and other selective estrogen receptor modulators (SERMs) discussed later in this section, show estrogenic and antiestrogenic effects on end-organs, which differ in part from those caused by tamoxifen.

“Management of Breast Diseases” by Ismail Jatoi, Manfred Kaufmann
from Management of Breast Diseases
by Ismail Jatoi, Manfred Kaufmann
Springer Berlin Heidelberg, 2010

The use of SERMs tamoxifen and raloxifene to prevent initial malignancy in selected women who are at high risk for the development of breast cancer is under study.

“Introduction to Medical-Surgical Nursing” by Adrianne Dill Linton, PhD, RN, FAAN
from Introduction to Medical-Surgical Nursing
by Adrianne Dill Linton, PhD, RN, FAAN
Elsevier Health Sciences, 2015

This is accomplished by the inhibition of aromatase, which is responsible for the conversion of androgens to estrogens in the malignant breast cancer cells.

“Essentials of Medical Biochemistry: With Clinical Cases” by N. V. Bhagavan, Chung-Eun Ha
from Essentials of Medical Biochemistry: With Clinical Cases
by N. V. Bhagavan, Chung-Eun Ha
Elsevier Science, 2011

It is presumably oestrogens, too, that cause a small increase in risk of breast cancer during and immediately after pregnancy and the oestrogen component of the steroid contraceptives that causes a similar small increase in risk during their use and for a few years after their use is stopped.

“Oxford Textbook of Medicine” by D. A. Warrell, Timothy M. Cox, John D. Firth
from Oxford Textbook of Medicine
by D. A. Warrell, Timothy M. Cox, John D. Firth
Oxford University Press, 2005

Oktay Kutluk

Kutluk Oktay, MD, FACOG is one of the world's foremost experts in fertility preservation as well as ovarian stimulation and in vitro fertilization for infertility treatments. He developed and performed the world's first ovarian transplantation procedures as well as pioneered new ovarian stimulation protocols for embryo and oocyte freezing for breast and endometrial cancer patients.

Mail: [email protected]
Telephone: +1 (877) 492-3666

Bibliography: oktay_bibliography

View all posts


Your email address will not be published. Required fields are marked *

  • What do you have to do to get tested for the BRCA gene? Is it just a blood test? And do you HAVE to have a mastectomy if they say you have the mutation?

  • Both my mum and aunt had breast cancer and survived. I most likely will get it too. But what’s a 90% gene test result gonna tell you? You might be in the lucky 10%. To each their own, I am being as careful as possible & going to check-ups annually. No need to live in fear.

  • I’d be dead if I didn’t have a double mastectomy. I had a family history. Mother, 2 aunts, Grandma. Had DCIS in the one breast. I said if we are removing one we are doing both. Drs said i didnt really need to do that. Guess where the unseen BC was? Yep in the other breast and while not large, not exactly small either 1.6 Cm. And yet not seen on any of the mammogram or ultrasound. So if you think and feel you need a double mastectomy follow your need!

  • What does he mean by you had to have a mastectomy age 15.
    What kind of message is this?
    You can take other measures.
    This message is dangerous and false.

  • This video is soooooo old & antiquated!!! And so is this surgeons attitude. A surgeons job is never to “talk a patient out of” an option but rather present solid CURRENT facts. Keep in mind this is “just” a surgeon & not a molecular biologist nor medical oncologist. In many cases of DCIS in humans, there’s often already early dissemination of dormant breast cancer cells already present in the bone marrow. It’s been in the medical literature for a decade, likely more. Most breast surgeons won’t know this which is fine… Surgeons are highly specialized technicians, usually not lateral, big picture thinkers nor scientists… which is, unless they’re dismissive like this example.

  • She only talks her patients out of a bilateral mastectomy so she has future business to keep her afloat. She obviously doesn’t care or support her patients’ decisions on THEIR health